| | | | | | | | | | | | | | | | |
| |
| Issue Date FY: 2024 ( Subtotal = $2,569,058 ) |
| 2024 | 2024 | JAEB CENTER FOR HEALTH RESEARCH FOUNDATION, INC. | 15310 AMBERLY DR STE 350 | TAMPA | FL | 33647-1642 | HILLSBOROUGH | USA | UG1EY011751 | Pediatric Eye Disease Investigator Group Coordinating Center | 002 | 28 | NIH | 1/22/2024 | $0 |
| 2024 | 2024 | JAEB CENTER FOR HEALTH RESEARCH FOUNDATION, INC. | 15310 AMBERLY DR STE 350 | TAMPA | FL | 33647-1642 | HILLSBOROUGH | USA | UG1EY014231 | DRCR Retina Network | 002 | 23 | NIH | 1/22/2024 | $0 |
| 2024 | 2024 | JAEB CENTER FOR HEALTH RESEARCH FOUNDATION, INC. | 15310 AMBERLY DR STE 350 | TAMPA | FL | 33647-1642 | HILLSBOROUGH | USA | UG1EY011751 | Pediatric Eye Disease Investigator Group Coordinating Center | 001 | 28 | NIH | 12/29/2023 | $1,412,994 |
| 2024 | 2024 | JAEB CENTER FOR HEALTH RESEARCH FOUNDATION, INC. | 15310 AMBERLY DR STE 350 | TAMPA | FL | 33647-1642 | HILLSBOROUGH | USA | UG1EY014231 | DRCR Retina Network | 001 | 23 | NIH | 12/29/2023 | $1,156,064 |
| 2024 | 2023 | JAEB CENTER FOR HEALTH RESEARCH FOUNDATION, INC. | 15310 AMBERLY DR STE 350 | TAMPA | FL | 33647-1642 | HILLSBOROUGH | USA | UG1EY014231 | DRCR Retina Network | 000 | 22 | NIH | 12/22/2023 | $0 |
| 2024 | 2023 | JAEB CENTER FOR HEALTH RESEARCH FOUNDATION, INC. | 15310 AMBERLY DR STE 350 | TAMPA | FL | 33647-1642 | HILLSBOROUGH | USA | UG1EY014231 | DRCR Retina Network | 000 | 22 | NIH | 12/22/2023 | $0 |
| 2024 | 2023 | JAEB CENTER FOR HEALTH RESEARCH FOUNDATION, INC. | 15310 AMBERLY DR STE 350 | TAMPA | FL | 33647-1642 | HILLSBOROUGH | USA | UG1EY011751 | Pediatric Eye Disease Investigator Group Coordinating Center | 000 | 27 | NIH | 12/22/2023 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $13,795,468 ) |
| 2023 | 2023 | JAEB CENTER FOR HEALTH RESEARCH FOUNDATION, INC. | 15310 AMBERLY DR STE 350 | TAMPA | FL | 33647-1642 | HILLSBOROUGH | USA | UG1EY011751 | Pediatric Eye Disease Investigator Group Coordinating Center | 000 | 27 | NIH | 2/21/2023 | $4,155,551 |
| 2023 | 2023 | JAEB CENTER FOR HEALTH RESEARCH FOUNDATION, INC. | 15310 AMBERLY DR STE 350 | TAMPA | FL | 33647-1642 | HILLSBOROUGH | USA | UG1EY014231 | DRCR Retina Network | 000 | 22 | NIH | 1/27/2023 | $2,000,000 |
| 2023 | 2023 | JAEB CENTER FOR HEALTH RESEARCH FOUNDATION, INC. | 15310 AMBERLY DR STE 350 | TAMPA | FL | 33647-1642 | HILLSBOROUGH | USA | UG1EY014231 | DRCR Retina Network | 000 | 22 | NIH | 1/27/2023 | $2,650,478 |
| 2023 | 2023 | JAEB CENTER FOR HEALTH RESEARCH FOUNDATION, INC. | 15310 AMBERLY DR STE 350 | TAMPA | FL | 33647-1642 | HILLSBOROUGH | USA | R01DK122603 | A Randomized Cross-Over Trial Evaluating Automated Insulin Delivery Technologies on Glycemic Outcomes and Quality of Life in Older Adults with Type 1 Diabetes | 000 | 4 | NIH | 1/20/2023 | $239,044 |
| 2023 | 2023 | JAEB CENTER FOR HEALTH RESEARCH FOUNDATION, INC. | 15310 AMBERLY DR STE 350 | TAMPA | FL | 33647-1642 | HILLSBOROUGH | USA | UG1EY011751 | Pediatric Eye Disease Investigator Group Coordinating Center | 001 | 27 | NIH | 9/20/2023 | $3,169,199 |
| 2023 | 2023 | JAEB CENTER FOR HEALTH RESEARCH FOUNDATION, INC. | 15310 AMBERLY DR STE 350 | TAMPA | FL | 33647-1642 | HILLSBOROUGH | USA | UG1EY030030 | Diabetes Endothelial Keratoplasty Study: Impact of Diabetes on Corneal Transplant Success and Cell Loss | 000 | 3 | NIH | 6/2/2023 | $1,608,633 |
| 2023 | 2022 | JAEB CENTER FOR HEALTH RESEARCH FOUNDATION, INC. | 15310 AMBERLY DR STE 350 | TAMPA | FL | 33647-1642 | HILLSBOROUGH | USA | R01FD007628 | Gyrate Atrophy Ocular and Systemic Study (GYROS) | 000 | 1 | FDA | 11/1/2022 | $0 |
| 2023 | 2022 | JAEB CENTER FOR HEALTH RESEARCH FOUNDATION, INC. | 15310 AMBERLY DR STE 350 | TAMPA | FL | 33647-1642 | HILLSBOROUGH | USA | R01FD007628 | Gyrate Atrophy Ocular and Systemic Study (GYROS) | 001 | 1 | FDA | 8/9/2023 | $0 |
| 2023 | 2022 | JAEB CENTER FOR HEALTH RESEARCH FOUNDATION, INC. | 15310 AMBERLY DR STE 350 | TAMPA | FL | 33647-1642 | HILLSBOROUGH | USA | R01FD007628 | Gyrate Atrophy Ocular and Systemic Study (GYROS) | 002 | 1 | FDA | 8/30/2023 | $0 |
| 2023 | 2020 | JAEB CENTER FOR HEALTH RESEARCH FOUNDATION, INC. | 15310 AMBERLY DR STE 350 | TAMPA | FL | 33647-1642 | HILLSBOROUGH | USA | UG1EY027725 | Safety and Feasibility of Cultivated Autologous Limbal Epithelial Cell (CALEC) Transplantation in the Treatment of Limbal Stem Cell Deficiency | 001 | 4 | NIH | 8/30/2023 | $0 |
| 2023 | 2020 | JAEB CENTER FOR HEALTH RESEARCH FOUNDATION, INC. | 15310 AMBERLY DR STE 350 | TAMPA | FL | 33647-1642 | HILLSBOROUGH | USA | UG1EY027725 | Safety and Feasibility of Cultivated Autologous Limbal Epithelial Cell (CALEC) Transplantation in the Treatment of Limbal Stem Cell Deficiency | 000 | 4 | NIH | 2/21/2023 | $0 |
| 2023 | 2016 | JAEB CENTER FOR HEALTH RESEARCH FOUNDATION, INC. | 15310 AMBERLY DR STE 350 | TAMPA | FL | 33647-1642 | HILLSBOROUGH | USA | U10EY020797 | Effect of Corneal Preservation Time on Long-Term Graft Success (CPTS) | 000 | 5 | NIH | 10/1/2022 | -$27,437 |
|
| Issue Date FY: 2022 ( Subtotal = $15,902,234 ) |
| 2022 | 2022 | JAEB CENTER FOR HEALTH RESEARCH FOUNDATION, INC. | 15310 AMBERLY DR STE 350 | TAMPA | FL | 33647-1642 | HILLSBOROUGH | USA | UG1EY014231 | DRCR Retina Network | 000 | 21 | NIH | 1/10/2022 | $7,544,793 |
| 2022 | 2022 | JAEB CENTER FOR HEALTH RESEARCH FOUNDATION, INC. | 15310 AMBERLY DR STE 350 | TAMPA | FL | 33647-1642 | HILLSBOROUGH | USA | UG1EY014231 | DRCR Retina Network | 001 | 21 | NIH | 2/24/2022 | $2,000,000 |
| 2022 | 2022 | JAEB CENTER FOR HEALTH RESEARCH FOUNDATION, INC. | 15310 AMBERLY DR STE 350 | TAMPA | FL | 33647-1642 | HILLSBOROUGH | USA | UG1EY030030 | Diabetes Endothelial Keratoplasty Study: Impact of Diabetes on Corneal Transplant Success and Cell Loss | 001 | 2 | NIH | 6/13/2022 | $1,138,602 |
| 2022 | 2022 | JAEB CENTER FOR HEALTH RESEARCH FOUNDATION, INC. | 15310 AMBERLY DR STE 350 | TAMPA | FL | 33647-1642 | HILLSBOROUGH | USA | R01FD007628 | Gyrate Atrophy Ocular and Systemic Study (GYROS) | 000 | 1 | FDA | 9/8/2022 | $400,000 |
| 2022 | 2022 | JAEB CENTER FOR HEALTH RESEARCH FOUNDATION, INC. | 15310 AMBERLY DR STE 350 | TAMPA | FL | 33647-1642 | HILLSBOROUGH | USA | R01DK122603 | A Randomized Cross-Over Trial Evaluating Automated Insulin Delivery Technologies on Glycemic Outcomes and Quality of Life in Older Adults with Type 1 Diabetes | 002 | 4 | NIH | 5/10/2022 | $565,751 |
| 2022 | 2022 | JAEB CENTER FOR HEALTH RESEARCH FOUNDATION, INC. | 15310 AMBERLY DR STE 350 | TAMPA | FL | 33647-1642 | HILLSBOROUGH | USA | UG1EY011751 | Pediatric Eye Disease Investigator Group Coordinating Center | 000 | 26 | NIH | 1/13/2022 | $4,253,088 |
| 2022 | 2022 | JAEB CENTER FOR HEALTH RESEARCH FOUNDATION, INC. | 15310 AMBERLY DR STE 350 | TAMPA | FL | 33647-1642 | HILLSBOROUGH | USA | R01DK122603 | A Randomized Cross-Over Trial Evaluating Automated Insulin Delivery Technologies on Glycemic Outcomes and Quality of Life in Older Adults with Type 1 Diabetes | 003 | 4 | NIH | 5/26/2022 | $0 |
| 2022 | 2021 | JAEB CENTER FOR HEALTH RESEARCH FOUNDATION, INC. | 15310 AMBERLY DR STE 350 | TAMPA | FL | 33647-1642 | HILLSBOROUGH | USA | UG1EY030030 | Diabetes Endothelial Keratoplasty Study: Impact of Diabetes on Corneal Transplant Success and Cell Loss | 000 | 1 | NIH | 6/10/2022 | $0 |
| 2022 | 2021 | JAEB CENTER FOR HEALTH RESEARCH FOUNDATION, INC. | 15310 AMBERLY DR STE 350 | TAMPA | FL | 33647-1642 | HILLSBOROUGH | USA | R01DK122603 | A Randomized Cross-Over Trial Evaluating Automated Insulin Delivery Technologies on Glycemic Outcomes and Quality of Life in Older Adults with Type 1 Diabetes | 001 | 3 | NIH | 2/8/2022 | $0 |
| 2022 | 2021 | JAEB CENTER FOR HEALTH RESEARCH FOUNDATION, INC. | 15310 AMBERLY DR STE 350 | TAMPA | FL | 33647-1642 | HILLSBOROUGH | USA | R01DK122603 | A Randomized Cross-Over Trial Evaluating Automated Insulin Delivery Technologies on Glycemic Outcomes and Quality of Life in Older Adults with Type 1 Diabetes | 000 | 3 | NIH | 11/2/2021 | $0 |
| 2022 | 2020 | JAEB CENTER FOR HEALTH RESEARCH FOUNDATION, INC. | 15310 AMBERLY DR STE 350 | TAMPA | FL | 33647-1642 | HILLSBOROUGH | USA | U24DK123768 | Data Coordinating Center for Artificial Pancreas Studies | 000 | 1 | NIH | 12/23/2021 | $0 |
| 2022 | 2020 | JAEB CENTER FOR HEALTH RESEARCH FOUNDATION, INC. | 15310 AMBERLY DR STE 350 | TAMPA | FL | 33647-1642 | HILLSBOROUGH | USA | UG1EY027725 | Safety and Feasibility of Cultivated Autologous Limbal Epithelial Cell (CALEC) Transplantation in the Treatment of Limbal Stem Cell Deficiency | 000 | 4 | NIH | 7/20/2022 | $0 |
|
| Issue Date FY: 2021 ( Subtotal = $18,529,631 ) |
| 2021 | 2021 | JAEB CENTER FOR HEALTH RESEARCH FOUNDATION, INC. | 15310 AMBERLY DR STE 350 | TAMPA | FL | 33647-1642 | HILLSBOROUGH | USA | R01DK122603 | A Randomized Cross-Over Trial Evaluating Automated Insulin Delivery Technologies on Glycemic Outcomes and Quality of Life in Older Adults with Type 1 Diabetes | 000 | 3 | NIH | 5/7/2021 | $638,470 |
| 2021 | 2021 | JAEB CENTER FOR HEALTH RESEARCH FOUNDATION, INC. | 15310 AMBERLY DR STE 350 | TAMPA | FL | 33647-1642 | HILLSBOROUGH | USA | UG1EY014231 | DRCR Retina Network | 000 | 20 | NIH | 3/24/2021 | $7,588,029 |
| 2021 | 2021 | JAEB CENTER FOR HEALTH RESEARCH FOUNDATION, INC. | 15310 AMBERLY DR STE 350 | TAMPA | FL | 33647-1642 | HILLSBOROUGH | USA | UG1EY014231 | DRCR Retina Network | 001 | 20 | NIH | 5/12/2021 | $0 |
| 2021 | 2021 | JAEB CENTER FOR HEALTH RESEARCH FOUNDATION, INC. | 15310 AMBERLY DR STE 350 | TAMPA | FL | 33647-1642 | HILLSBOROUGH | USA | UG1EY014231 | DRCR Retina Network | 001 | 20 | NIH | 5/12/2021 | $0 |
| 2021 | 2021 | JAEB CENTER FOR HEALTH RESEARCH FOUNDATION, INC. | 15310 AMBERLY DR STE 350 | TAMPA | FL | 33647-1642 | HILLSBOROUGH | USA | UG1EY030030 | Diabetes Endothelial Keratoplasty Study: Impact of Diabetes on Corneal Transplant Success and Cell Loss | 000 | 1 | NIH | 4/21/2021 | $831,294 |
| 2021 | 2021 | JAEB CENTER FOR HEALTH RESEARCH FOUNDATION, INC. | 15310 AMBERLY DR STE 350 | TAMPA | FL | 33647-1642 | HILLSBOROUGH | USA | UG1EY014231 | DRCR Retina Network | 000 | 20 | NIH | 3/24/2021 | $2,000,000 |
| 2021 | 2021 | JAEB CENTER FOR HEALTH RESEARCH FOUNDATION, INC. | 15310 AMBERLY DR STE 350 | TAMPA | FL | 33647-1642 | HILLSBOROUGH | USA | R01DK122603 | A Randomized Cross-Over Trial Evaluating Automated Insulin Delivery Technologies on Glycemic Outcomes and Quality of Life in Older Adults with Type 1 Diabetes | 001 | 3 | NIH | 7/21/2021 | $0 |
| 2021 | 2021 | JAEB CENTER FOR HEALTH RESEARCH FOUNDATION, INC. | 15310 AMBERLY DR STE 350 | TAMPA | FL | 33647-1642 | HILLSBOROUGH | USA | UG1EY011751 | Pediatric Eye Disease Investigator Group Coordinating Center | 000 | 25 | NIH | 3/24/2021 | $7,471,838 |
|
| Issue Date FY: 2020 ( Subtotal = $16,635,090 ) (Continued on the next page) |
| 2020 | 2020 | JAEB CENTER FOR HEALTH RESEARCH FOUNDATION, INC. | 15310 AMBERLY DR STE 350 | TAMPA | FL | 33647-1642 | HILLSBOROUGH | USA | UG1EY011751 | Pediatric Eye Disease Investigator Group Coordinating Center | 000 | 24 | NIH | 2/11/2020 | $6,661,239 |
| 2020 | 2020 | JAEB CENTER FOR HEALTH RESEARCH FOUNDATION, INC. | 15310 AMBERLY DR STE 350 | TAMPA | FL | 33647-1642 | HILLSBOROUGH | USA | R01DK122603 | A Randomized Cross-Over Trial Evaluating Automated Insulin Delivery Technologies on Glycemic Outcomes and Quality of Life in Older Adults with Type 1 Diabetes | 001 | 2 | NIH | 4/22/2020 | $657,345 |
| 2020 | 2020 | JAEB CENTER FOR HEALTH RESEARCH FOUNDATION, INC. | 15310 AMBERLY DR STE 350 | TAMPA | FL | 33647-1642 | HILLSBOROUGH | USA | UG1EY014231 | DRCR Retina Network | 000 | 19 | NIH | 1/29/2020 | $6,500,000 |
| 2020 | 2020 | JAEB CENTER FOR HEALTH RESEARCH FOUNDATION, INC. | 15310 AMBERLY DR STE 350 | TAMPA | FL | 33647-1642 | HILLSBOROUGH | USA | UG1EY014231 | DRCR Retina Network | 000 | 19 | NIH | 1/29/2020 | $2,000,000 |
| 2020 | 2020 | JAEB CENTER FOR HEALTH RESEARCH FOUNDATION, INC. | 15310 AMBERLY DR STE 350 | TAMPA | FL | 33647-1642 | HILLSBOROUGH | USA | U24DK123768 | Data Coordinating Center for Artificial Pancreas Studies | 001 | 1 | NIH | 7/30/2020 | $296,393 |
| 2020 | 2020 | JAEB CENTER FOR HEALTH RESEARCH FOUNDATION, INC. | 15310 AMBERLY DR STE 350 | TAMPA | FL | 33647-1642 | HILLSBOROUGH | USA | UG1EY027725 | Safety and Feasibility of Cultivated Autologous Limbal Epithelial Cell (CALEC) Transplantation in the Treatment of Limbal Stem Cell Deficiency | 001 | 4 | NIH | 7/23/2020 | $330,916 |
|